– USA, CA – Vantage Health Inc. (OTCQB:VNTH) today announced the appointment of Tony van Bijleveld as an independent member of the Board of Directors of Vantage Health, Inc.
Mr. van Bijleveld is currently General Manager with leading drug manufacturer Patheon/DPX. Patheon is a leading global provider of contract drug development and manufacturing services. Their integrated network consists of seven development centers of excellence and thirteen manufacturing facilities across North America, Asia and Europe. Patheon provides pharmaceutical and biotechnology companies with direct access to the expertise, quality and full range of solid and sterile dosage forms to bring drug candidates from preclinical stages through production, and launch products anywhere in the world.
Up until this past spring, Mr. van Bijleveld was the General Manager of Europe for Alliance Boots which is 45% owned by Walgreens. In this capacity he was responsible for European country operations and logistics. Alliance Boots, with a presence in more than 25 countries and over 108,000 employees is a leading international, pharmacy-led health and beauty group delivering a range of products and services to customers. Their focus is on pharmacy-led retailing and pharmaceutical wholesaling and distribution. Alliance Boots operate more than 3,150 health & beauty retail stores, of which just over 3,050 have a pharmacy.
Mr. van Bijleveld has been instrumental in the development of top-performing global businesses in diagnostics, pharmaceuticals and biotechnology industries in over 30 countries, reflecting his experience in general management, marketing and sales management, acquisitions, operational excellence, and licensing and business development.
Over the past 30 years he has served in a variety of senior executive capacities in the pharmaceutical and biotech industry including: Managing Director of United Drug PLC, President/General Manager Russia for Schering Plough/MSD, SVP of Organon Biosciences, and Managing Director of KCL Foundation Labs. A native Australian, Mr. van Bijleveld has earned advanced degrees in Pharmacology, Biochemistry, Engineering and an MBA, from colleges in Australia, Holland and Candean.
More news will be forthcoming this week as the Company expands and reconstitutes its Board.
About Vantage Health Inc.
Vantage Health Inc. – a mobile health technology company – is developing personalized and point-of-care screening using Apps based upon chemical sensing residing within a small device attached to a smartphone. With its foundations in advanced nanotechnology, the company’s first product, the Vantage Health Sensor, which is in development, is the convergence of nano-electronics, bio-informatics, and wireless technology to create the next generation mobile health application. The first mobile App is expected to be for lung cancer screening with additional mobile healthcare Apps in the planning stages. The company has offices in Redwood City, CA and New York.
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
